Circulating Levels of Urokinase-Type Plasminogen Activator Receptor and D-Dimer in Patients With Hematological Malignancies-Reference-Cited by-同舟云学术

Circulating Levels of Urokinase-Type Plasminogen Activator Receptor and D-Dimer in Patients With Hematological Malignancies

Published:2015-10 Issue:10 Volume:15 Page:621-626
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Rubio-Jurado Benjamín,Tello-González Alejandra,Bustamante-Chávez Lili,de la Peña Aurora,Riebeling-Navarro Carlos,Nava-Zavala Arnulfo Hernan^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference28 articles.

1. Translational research on u-PAR;Allgayer;Eur J Cancer,2010

2. New insights into the molecular mechanisms of the fibrinolytic system;Rijken;J Thromb Haemost,2009

3. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients;Koch;Crit Care,2011

4. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis;Savva;J Infect,2011

5. CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review;Béné;Leukemia,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of plasma soluble urokinase plasminogen activator receptor (SuPAR) levels in ulcerative colitis;Arab Journal of Gastroenterology;2023-08

2. Plasminogen Activator Inhibitor-1 in Acute Myeloid Leukemia: Is It Useful in Predicting Response to Induction Remission Therapy?;Open Access Macedonian Journal of Medical Sciences;2022-07-16

3. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation;Frontiers in Immunology;2021-12-02

4. El estado protrombótico en los pacientes con cáncer;Gaceta Mexicana de Oncolog�a;2021-03-01

5. The prothrombotic state in cancer;Advances in Clinical Chemistry;2021